Lifestyle Medicine. This presentation will:
|
|
- Cameron Harper
- 5 years ago
- Views:
Transcription
1 Lifestyle Medicine This presentation will: Identify barriers to lifestyle therapy and develop strategies to promote behavioral changes in patients with obesity and/or T2D. AACE = American Association of Clinical Endocrinologists
2 IDF Diabetes Atlas: Diabetes Prevalence 415 million people worldwide have diabetes By 2040, this number will rise to 642 million ( million) AFR = Africa; EUR = Europe; IDF = International Diabetes Federation; MENA = Middle East and North Africa; NAC = North America and Caribbean; SACA = South and Central America; SEA = South-East Asia; WP = Western Pacific. IDF Diabetes Atlas, 7 th Edition
3 Age-Adjusted Prevalence of Obesity and Diagnosed Diabetes Among U.S. Adults Obesity (BMI 30 kg/m 2 ) No Data <14.0% 14.0% 17.9% 18.0% 21.9% 22.0% 25.9% > 26.0% 1994 Diabetes No Data <4.5% 4.5% 5.9% 6.0% 7.4% 7.5% 8.9% >9.0% BMI = body mass index; CDC = U.S. Center for Disease Control and Prevention. CDC s Division of Diabetes Translation. National Diabetes Surveillance System.
4 Adverse Health and Social Consequences Associated with Obesity PHYSICAL PSYCHOSOCIAL FUNCTIONAL Cancer Depression Absenteeism from school or work Cardiovascular disease Discrimination Disability Cholestasis Low self-esteem Disqualification from active military/fire/police services Dyslipidemia Negative body image Low physical fitness level Gallbladder disease Negative stereotyping Mobility limitations Glucose intolerance and insulin resistance Social marginalization Reduced academic performance Hepatic steatosis Teasing and bullying Reduced productivity Hypertension Hyperuricemia and gout Menstrual abnormalities Orthopedic problems Reduction of cerebral blood flow Sleep apnea T2DM Unemployment T2DM = type 2 diabetes mellitus. American Academy of Family Physicians. Accessed April 15, 2015.
5 What Are the Health Risks Associated with Prediabetes? Progression to diabetes: on average, 11% of people with prediabetes develop type 2 diabetes each year (DPP) Other studies: majority with prediabetes develop type 2 diabetes in 10 years Presence of microvascular complications at onset of diabetes 50% higher risk of CVD, CAD and stroke CAD = coronary artery disease; CVD = cardiovascular disease; DPP = Diabetes Prevention Program. NDIC/NIDDK. Diabetes Prevention Program. Accessed May 1, 2013.
6 Diabetes Incidence per 100 Person-Years Intensive Lifestyle Intervention Prevents Progression from IGT to T2DM Diabetes Prevention Program (N=3234) % 31% Intensive lifestyle intervention*, (n=1079) IGT = impaired glucose tolerance; T2DM = type 2 diabetes mellitus. DPP Research Group. N Engl J Med. 2002;346: Metformin 850mg BID, (n=1073) Placebo, (n=1082) * Goal: 7% reduction in baseline body weight through low-calorie, low-fat meal plan and 150 min/week moderate intensity physical activity.
7 Diabetes Incidence per 100 Person-Years Intensive Lifestyle Intervention Effectively Prevents T2DM as Populations Age Diabetes Prevention Program (DPP) (N=3234) 48% 59% 71% DPP Research Group. N Engl J Med. 2002;346: Age (years) * Goal: 7% reduction in baseline body weight through low-calorie, low-fat meal plan and 150 min/week moderate intensity physical activity. DPP = Diabetes Prevention Program; T2DM = type 2 diabetes mellitus.
8 Diabetes Mellitus Reduction (%) Is It Possible to Delay the Onset of T2DM? 80 74% 72% >5% loss 42% 58% 55% 41% 62% Finnish-Diet+ Exercise Da Qing Diet + Exercise DPP-Lifestyle 30 31% 25% DPP-Metformin STOP-NIDDM 20 TRIPOD 10 0 Diabetes Prevention Clinical Trials XENDOS DREAM ActNOW DPP = Diabetes Prevention Program; DREAM = Diabetes Reduction Assessment with Ramipril & Rosiglitazone Medication; STOP-NIDDM = Study to Prevent Non-Insulin-Dependent Diabetes Mellitus; T2DM = type 2 diabetes mellitus; TRIPOD = Troglitazone in the Prevention of Diabetes; XENDOS = XEnical in the Prevention of Diabetes in Obese Subjects. Buchanan T, et al. Diabetes 2002; 51(9): ; Chiasson JL, et al. Lancet 2002; 359: ; Da Qing, et al. Diabetes Care. 1997; 20: ; Gerstein H, et al. Lancet 2006; 368: ; Nathan DM, et al. N Engl J Med 2002; 346: ; Torgerson JS, et al. Diabetes Care 2004; 27 (1): ; Tuomilehto J, et al. N Engl J Med 2001; 344:
9 Interventions to Reduce the Risks Associated with Prediabetes Intensive lifestyle management is the cornerstone of all prevention efforts No pharmacologic agents are currently approved for the management of prediabetes Pharmacotherapy targeted at glucose may be considered in high-risk patients after individual risk:benefit analysis
10 Identification and Screening: BMI Is the Starting Point 2013 AHA/ACC/TOS Obesity Guidelines identify patients who need to lose weight Measure height and weight and calculate BMI at annual visits or more frequently for all patients Use BMI cut points to classify patients with overweight or obesity BMI is used as an estimate of increased adverse health consequences ACC = American College of Cardiology; AHA = American Heart Association; BMI = body mass index; TOS = The Obesity Society. Jensen MD, et al. Circulation. 129(25 suppl 2):S102 S138, 2014.
11 Obesity Classification: BMI Patients with overweight/obesity = increased body fat (adiposity) Overweight and obesity classification: body mass index (BMI) in kg/m 2 Normal weight ( ) Overweight ( ) Class I obesity ( ) Class II obesity ( ) Class III obesity ( 40.0) ACTION ITEM: For all patients, calculate BMI at annual visits or more frequently and identify body weight classification. BMI = body mass index. Seger JC, et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians Accessed April 6, 2015.
12 Relationship Between BMI and Risk of T2DM BMI = body mass index; T2DM = type 2 diabetes mellitus. Chan JM, et al. Diabetes Care. 17(9): Colditz GA, et al. Ann Intern Med. 122(7):
13 The Role of the Physician >50% of visits no BMI measured If BMI data available >70% of obese patients were not diagnosed If obesity diagnosed >63% received no counseling (even with risk factors) BMI = body mass index. Ma J, et al. Adult obesity and office-based quality of care in the US. Obesity 17: , 2009.
14 Obesity Classification: Waist Circumference (WC) Patients with overweight/obesity = increased body fat (adiposity) Overweight and obesity classification: waist circumference (WC) Men abdominal obesity 40 in. ( 102 cm)* Women abdominal obesity 35 in. ( 88 cm)* ACTION ITEM: Measure WC at annual visits or more frequently in patients with overweight or obesity. WC = waist circumference. *Different WC abdominal obesity cutoff points may be appropriate for different races, such as 90 cm for Asian men and 80 cm for Asian women. Seger JC, et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians Accessed April 6, 2015.
15 Treatment: Modest Weight Loss = Major Health Benefits 5% weight loss 10% weight loss 15% weight loss T2DM prevention With T2DM: better glycemic control/ medication reduction Improvement in urinary stress incontinence, mobility, joint pain, weight-related QOL Improvements in CVD risk factors (HDL-C, TG, BP) Previous improvements Sleep apnea Diabetes remission? Previous improvements CVD mortality All-cause mortality and reduction in cancer risk (with surgical weight loss) ACTION ITEM: Consider the benefits that a 5% to 10% weight loss will have on your patients with overweight or obesity. BP = blood pressure; CVD = cardiovascular disease; HDL-C = high density lipoprotein-cholesterol; QOL = quality of life; T2DM = type 2 diabetes mellitus; TG = triglycerides. Blackburn G. Obes Res. 3(suppl 2):211s-216s Christou NV, et al. Surg Obes Relat Dis. 4(6): Foster GD, et al. Arch Intern Med. 169(17): Gregg EW, et al. JAMA. 308(23): Sjostrom L, et al. J Intern Med. 273(3):
16 Determinants of Body Weight Genes Protective and at risk alleles for weight gain Race (ancestral admixture) Gene-gene interactions Environment Food availability Food quality Built environment Socioeconomic status Education Biological factors In utero environment Birthweight Gender Age Concurrent diseases Behavior Dietary preferences Physical activity Psychological factors Cultural factors Diurnal life patterns
17 The Toxic Environment High-Calorie Food is Highly palatable Near-ubiquitous Heavily advertised Supersized Inexpensive Brownell KD & Horgen KB. Food Fight. New York: McGraw-Hill; 2003.
18 Garvey et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3). Garber et al.consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm Executive Summary. Endocr Pract. 2016;22(No. 1) Lifestyle Modification: Diet Guidelines and Recommendations Goal of 5% to 15% weight loss Caloric deficit of ~500 to 750 kcal/day (kcal = ~10x BW in lbs) Balanced, healthful diet with 50% to 55% carb, 30% fat, 15% protein BW = body weight.
19 Macronutrient Diet Composition Diets enriched in the following are associated with a decrease in insulin sensitivity Total fat Saturated fat Trans-fat Refined grains Diets enriched in the following are associated with an increase in insulin sensitivity Fiber Fruits/vegetables Polyunsaturated fats Monounsaturated fats Whole grain Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53. Garvey WT, Lara-Castro C. J Clin Endocrinol Metab. 2004;89:
20 Strategies for Maintaining Weight Loss From the Academy of Nutrition and Dietetics Evidence Analysis Library: Reduced calorie diet Distribute calories throughout day Portion control Avoid large meals, especially later in day Meal replacements can be helpful Other Strategies: Increasing fruits, vegetables, and low-fat dairy effective in the Weight Loss Maintenance Clinical Trial National Weight Control Registry promotes eating breakfast, physical activity (1.5 hr/day) and self-monitoring Garvey et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3). Garber et al.consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm Executive Summary. Endocr Pract. 2016;22(No. 1). Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.
21 Sedentary Lifestyles
22 Garvey et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3). Garber et al.consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm Executive Summary. Endocr Pract. 2016;22(No. 1) Lifestyle Modification: Physical Activity Guidelines and Recommendations Talk about physical activity (not exercise ) Some is better than none 150 min/wk of moderate intensity activity Both aerobic (endurance) and strengthening (resistance) activity are beneficial
23 AACE Physical Activity Recommendations Patients 150 minutes per week of moderate-intensity exercise Strength training Aerobic exercise (e.g., walking, stair climbing) Increase as tolerated Use community engagement or professional trainer to help with motivation Healthcare Professionals Exude positive attitude Evaluate for contraindications and/or limitations to increased physical activity before patient begins or intensifies exercise program Develop exercise recommendations according to individual goals and limitations Set realistic goals and schedules AACE = American Association of Clinical Endocrinologists; HR = heart rate. Garvey et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Suppl 3). Garber et al.consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm Executive Summary. Endocr Pract. 2016;22(No. 1). Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.
24 Motivational Interviewing Encourage collaboration Let s put our heads together and review the options. Support autonomy and problem-solving; remember, 99% of outcomes are the patient s Develop motivation by eliciting change talk Ask open-ended, motivational questions What do you want to accomplish in this visit today? What is the most important concern to you about your diabetes right now? Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.
25 Motivational Interviewing Ask permission before giving advice Ask: May I propose a plan? or What about? Avoid: You should eat less and walk more. Approach with curiosity or invitation Say: I wonder or One option could be Invite: How about week or so trial of? or Some people with diabetes have found Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.
26 Motivational Empowerment Focus on: Optimism: I think you re onto something. Strengths: What are your strongest areas in managing your diabetes? What are you most comfortable with? Legitimizing experiences: I know what you mean about shopping when hungry. If I stop at the store on my way home from work, I always buy too much. Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.
27
28 Conditions for Success Engagement with other health team members Support at home (and at work) Patience Persistence Set realistic goals The weight treatment goal is to lose 5 to 10% of current body weight over the next 6 to 12 months. Perpetual goal until BMI is 18.5 to 24.9 kg/m 2 BMI = body mass index.
29 Reduction in Mortality with Modest Weight Loss Effects of Weight Loss in Type 2 Diabetes Every kg of weight loss is associated with 3 to 4 months of improved survival In a prospective analysis of 5000 people with type 2 diabetes, 35% reported intentional weight loss; this subgroup experienced a 25% reduction in mortality over 12 years Alternately, a 5-kg weight gain increases coronary heart disease risk by 30% ean ME, et al. Diabet Med. 1990;7: ; Williamson DF, et al. Diabetes Care. 2000;23: nderson JW et al. J Am Coll Nutr. 2003;22:331-9.
Lifestyle Medicine. Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee
Lifestyle Medicine Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing
More informationLifestyle Medicine. This presentation will:
Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes,
More informationLifestyle Medicine. This presentation will:
Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes,
More informationLifestyle Medicine. This presentation will:
Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes,
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationPresenter Disclosure Information
Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationDIABETES. A growing problem
DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought
More informationDiscussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting
Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be
More informationDonna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico
Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Presented in Collaboration with New Mexico Health Care Takes On Diabetes Discuss the burden and challenges prediabetes presents in New Mexico.
More informationSTATE OF THE STATE: TYPE II DIABETES
STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES
More informationPrediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD
Prediabetes & Type 2 Diabetes Prevention Jacob M. Haus, PHD Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants:
More informationNutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE
Nutritional Aspects of Obesity Management Christy Olson MS, RD, LD, CDE Relevant Disclosure and Resolution Under Accreditation Council for Continuing Medical Education guidelines disclosure must be made
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationPart 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.
Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes
More informationDiabetes and Weight Management: Tools to Affect Patient Outcomes
Diabetes and Weight Management: Tools to Affect Patient Outcomes Today s discussion Review the problem of diabetes and the importance of lifestyle intervention Identify current research supporting the
More informationNutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives
Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives Margo N. Woods, D.Sc. 1. Discuss the increase in the incidence and prevalence of type
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationTreating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition
Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationDietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD
Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationEdward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver
Edward Melanson, Ph.D., Associate Professor, Division of Endocrinology, Metabolism, and Diabetes University of Colorado Denver 45 y/o man Medications: none Social Hx: moderate alcohol intake (1-2 cans
More informationInterdisciplinary Certification in Obesity and Weight Management Detailed Content Outline
1. Patient Assessment and Development of Treatment Plan (35 Items) A. Patient History and Current Status 1. Collect patient assessment information: a. weight history, including development genetics growth
More informationPrediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes!
Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Jaini Patel, PharmD, BCACP Assistant Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Kathleen
More informationOBESITY: The Growing Epidemic and its Medical Impact
OBESITY: The Growing Epidemic and its Medical Impact Ray Plodkowski, MD Co-Chief, Chief, of Division of Medical Nutrition, University of Nevada School of Medicine. Chief, Endocrinology & Metabolism, Sachiko
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationWhat s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center
What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center Learning Objectives By the end of this presentation, participants should be able to: Discuss updates
More informationDisclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None
Disclosures None OBESITY Florencia Halperin, M.D. Medical Director, Program for Management Brigham and Women s Hospital Instructor in Medicine, Harvard Medical School Overview Obesity: Definition Definition
More informationJ. Michael Gonzalez-Campoy, MD, PhD, FACE Teresa Pearson, MS, RN, CDE, FAADE
SCREEN, COUNSEL, REFER AND FOLLOW-UP FOR DIABETES AND PREDIABETES J. Michael Gonzalez-Campoy, MD, PhD, FACE drmike@mncome.com Teresa Pearson, MS, RN, CDE, FAADE tpearson@hallelandhabicht.net Sponsored
More informationObesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.
Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link
More informationPrediabetes Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Disclosures/Conflict of Interest.
Prediabetes: You Can Help Your Patients Exit the Express Lane to Diabetes! Jaini Patel, PharmD, BCACP Assistant Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Kathleen
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationThe prevalence of obesity in adults has doubled over the past 30 years
Obesity in America: Facts and Fiction MICHAEL G. PERRI, PhD Professor, Clinical and Health Psychology Interim Dean, College of Public Health and Health Professions University of Florida Overview: Key Questions
More informationGoals of today s talk. How to Stop Prediabetes from Becoming Diabetes. Goals of today s talk. Type 2 diabetes mellitus
Goals of today s talk How to Stop Prediabetes from Becoming Diabetes Zara Frankel, MD Boulder Creek Family Medicine 303-720-6956 Diabetes is a devastating disease Prediabetes and diabetes are on different
More informationGPSF Annual Conference 2018 Non Communicable Diseases: An Overview Of The Twin Epidemics of Diabetes and Obesity - Diabesity
GPSF Annual Conference 2018 Non Communicable Diseases: An Overview Of The Twin Epidemics of Diabetes and Obesity - Diabesity Kwabena O.M. Adubofour, MD, FWACP, FACP Medical Director, East Main Clinic and
More informationWhat is Metabolic About Metabolic Surgery? The New ADA Recommendations
What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in
More informationThe National Diabetes Prevention Program in Washington State March 2012
The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.
More informationOBESITY IN PRIMARY CARE
OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading
More informationThe Diabetes Prevention Program: Call for Action
The Diabetes Prevention Program: Call for Action Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Harvard Medical
More informationCopyright 2017 by Sea Courses Inc.
Pre-Diabetes: Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical,
More informationOverweight is defined as a body mass
THE DANGEROUS LIAISON: WEIGHT GAIN AND ITS ASSOCIATED COMORBIDITIES * Zachary T. Bloomgarden, MD ABSTRACT Overweight and obesity have tangible physical consequences that affect mortality and economics,
More informationPreventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y
Preventing Diabetes 2018 K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y D A V I D G E F F E N S C H O O L O F M E D I C I N E A T U C L A CO-DIRECTOR,
More informationObesity in the Latino Community. Michael A. Rodriguez, MD, MPH UCLA Department of Family Medicine
Obesity in the Latino Community Michael A. Rodriguez, MD, MPH UCLA Department of Family Medicine Obesity Trends* Among U.S. Adults BRFSS, 1985 (*BMI 30, or ~ 30 lbs overweight for 5 4 woman) No Data
More informationHow Do We Treat Obesity? Lifestyle Intervention
How Do We Treat Obesity? Lifestyle Intervention Why Is Lifestyle Weight Management Important? Improved metabolic control Lower fasting blood glucose and prevent T2D Lower blood pressure and lipid profile
More informationThe Global Agenda for the Prevention of Diabetes: Research Opportunities
The Global Agenda for the Prevention of Diabetes: Research Opportunities William H. Herman, MD, MPH Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes Professor of Internal Medicine and Epidemiology
More informationType 2 Diabetes Mellitus 2011
2011 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetes Mellitus Diagnosis 2011 Diabetes Mellitus Fasting Glucose
More informationRandy Wexler, MD, MPH Associate Professor and Clinical Vice Chair Department of Family Medicine The Ohio State University Wexner Medical Center
Obesity Randy Wexler, MD, MPH Associate Professor and Clinical Vice Chair Department of Family Medicine The Ohio State University Wexner Medical Center US Adults Obesity prevalence ranges from 21.0% in
More informationTreating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background
Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More informationEpidemiology of Diabetes Mellitus in Asia
Epidemiology of Diabetes Mellitus in Asia Nam H. Cho Professor of Preventive Medicine Director of Clinical Epidemiology Ajou University School of Medicine and Hospital, Suwon Korea President-elect of International
More information1/28/2014. The Metabolic Syndrome: Early History. Insulin Resistance: Early Diagnosis and Treatment to Prevent Cardiovascular Disease
: Early Diagnosis and Treatment to Prevent Cardiovascular Disease Henry N. Ginsberg, M.D. Irving Professor of Medicine Columbia University College of Physicans and Surgeons The Metabolic Syndrome: Early
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationImplementing Type 2 Diabetes Prevention Programmes
Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected
More informationHow Do We Treat Obesity? Lifestyle Intervention
How Do We Treat Obesity? Lifestyle Intervention Why Is Lifestyle Weight Management Important? Improved metabolic control Lower fasting blood glucose and prevent T2D Lower blood pressure and lipid profile
More informationObesity and Medical Nutrition Therapy. Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018
Obesity and Medical Nutrition Therapy Deborah B. Munchmeyer Program Manager, SCDHHS Coverage and Benefit Design March 10, 2018 Obesity What, Why and How? Source: American Association of Clinical Endocrinologists
More informationLooking Toward State Health Assessment.
CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main
More informationWELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University
WELL-WOMAN EXAM REVEALS RISK Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University Disclaimer The information provided in this presentation is for informational
More informationNutritional Recommendations for the Diabetes Managements
In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful
More informationWhy Do We Care About Prediabetes?
Why Do We Care About Prediabetes? Complications of Diabetes Diabetic Retinopathy Leading cause of blindness in adults 1,2 Diabetic Nephropathy Leading cause of Kidney failure Stroke 2- to 4-fold increase
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationPre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes
Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including
More informationType 2 Diabetes in Adolescents
Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic
More informationOVERVIEW OF NUTRITION & HEALTH
OVERVIEW OF NUTRITION & HEALTH NUTR 2050 Nutrition for Nursing Professionals Mrs. Deborah A. Hutcheon, MS, RD, LD Lesson Objectives At the end of the lesson, the student will be able to: 1. Describe the
More informationDiabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?
Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of
More informationDiabetes is a condition with a huge health impact in Asia. More than half of all
Interventions to Change Health Behaviors and Prevention Rob M. van Dam, PhD Diabetes is a condition with a huge health impact in Asia. More than half of all people with diabetes live today in Asian countries,
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationDiabetes treatment by the algorithm
Diabetes treatment by the algorithm Joseph Dawley, M.D. Southwest Oklahoma Family Medicine Residency Oklahoma University Health Sciences Center Clinical Assistant Professor Objectives By the end of this
More informationScience of Obesity (I-2.28)
Science of Obesity (I-2.28) Dr Noha Nooh Lasheen Lecturer of Physiology Date :16 / 10 / 2016 Objectives By the end of this lecture, the student should be able to: Define energy, energy balance and obesity.
More informationHealth Score SM Member Guide
Health Score SM Member Guide Health Score Your Health Score is a unique, scientifically based assessment of seven critical health indicators gathered during your health screening. This number is where
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationStandards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE
Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People
More informationObesity D R. A I S H A H A L I E K H Z A I M Y
Obesity D R. A I S H A H A L I E K H Z A I M Y Objectives Definition Pathogenesis of obesity Factors predisposing to obesity Complications of obesity Assessment and screening of obesity Management of obesity
More informationBMI. Summary: Chapter 7: Body Weight and Body Composition. Obesity Trends
Chapter 7: Body Weight and Body Composition Obesity Trends What Is a Healthy Body Weight? There is no ideal body weight for each person, but there are ranges for a healthy body weight A healthy body weight
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationHow does the LIFESTEPS Weight Management Program support diabetes prevention?
LIFESTEPS and Diabetes Prevention How does the LIFESTEPS Weight Management Program support diabetes prevention? The LIFESTEPS Weight Management Program (LIFESTEPS ) is a cognitive-behavioral program designed
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More informationBefore the Pre. PREDIABETES Diagnosis, Management, Treatment. A few thoughts on diabetes.
PREDIABETES Diagnosis, Management, Treatment Before the Pre A few thoughts on diabetes. James Lenhard, MD Director, Diabetes and Metabolic Diseases Center Christiana Care Health System JLenhard@ChristianaCare.org
More informationRisks and benefits of weight loss: challenges to obesity research
European Heart Journal Supplements (2005) 7 (Supplement L), L27 L31 doi:10.1093/eurheartj/sui083 Risks and benefits of weight loss: challenges to obesity research Donna Ryan* Pennington Biomedical Research
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationHow do we adapt diet approaches for patients with obesity with or without diabetes? Therese Coleman Dietitian
How do we adapt diet approaches for patients with obesity with or without diabetes? Therese Coleman Dietitian Developing a specialist weight management programme How did we adapt dietary approaches for
More informationLearning Objectives
Learning Objectives Assess the key findings of the McMaster meal replacement therapy (MRT) study Identify patients with T2DM who are candidates for MRT Develop a plan to implement partial MRT into a patient
More informationMoving Towards Primordial Prevention: Effective Interventions in the Clinical Setting Engaging and Empowering Patients
Moving Towards Primordial Prevention: Effective Interventions in the Clinical Setting Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. PREVALENCE OF CARDIOVASCULAR AND METABOLIC
More informationPrediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes
Prediabetes 101 What is it and what can I do about it? Patient Education Intermountainhealthcare.org/diabetes What do you already know about prediabetes? Fact or Fiction? There are often no symptoms of
More informationMyths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!
Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the
More informationReducing cardiovascular risk factors in patients with prediabetes
REVIEW Reducing cardiovascular risk factors in patients with prediabetes Jean-Louis Chiasson 1 & Sophie Bernard 1 Practice Points The prevalence of prediabetes is high and on the rise. Subjects with impaired
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationIt s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children
It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children Robert Ratner, M.D., F.A.C.P. Vice President for Scientific Affairs, Medstar Research Institute
More information«Πατσζαρκία και Καρδιαγγειακή Νόζος»
«Πατσζαρκία και Καρδιαγγειακή Νόζος» Δημήτρης Π. Παπαδόπουλος-FESC Clinical Assist. Professor George Washington University USA Επιμελητής Καρδιολογικής Κλινικής Π.Γ.Ν.Α. «ΛΑΪΚΟ» Υπεύθυνος Αντιυπερτασικού
More informationYou should try to lose some weight : an evidence- based approach to diet and weight loss Ridge Meadows Hospital Grand Rounds 14 September 2015
You should try to lose some weight : an evidence- based approach to diet and weight loss Ridge Meadows Hospital Grand Rounds 14 September 2015 Barbara Hughes, MD, FRCPC DefiniMons Body Mass Index=weight
More informationObesity Management in Type 2 Diabetes
Obesity Management in Type 2 Diabetes Clare J. Lee, MD, MHS Assistant Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University Disclosures None Objectives Describe
More informationPrevention and Management Of Obesity Adolescents & Children
Prevention and Management Of Obesity Adolescents & Children The Pediatric Obesity Prevention and Treatment Toolkit is available at: https://www.optimahealth.com/providers/clinical-reference/pediatric-obesity-prevention-andtreatment-toolkit
More informationPrimary Prevention of T2DM. KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009
Primary Prevention of T2DM KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009 Primary Prevention of T2DM Why to intervene? When to intervene? Lifestyle intervention Pharmacological
More information